Anxiety is a prevalent mental health condition affecting millions of individuals worldwide. It manifests in various ways, including worrying, fear, irritability, restlessness, sleep disturbances, concentration problems and physical symptoms like sweating, dizziness and shortness of breath. Anxiety disorders have diverse causes, including genetics, brain chemistry, life experiences and medical conditions. If you or someone you know […]
Transcranial magnetic stimulation (TMS) is a non-invasive brain stimulation therapy that has gained recognition for its effectiveness in treating major depressive disorder (MDD). This innovative treatment modality utilizes a magnetic pulser to create a focused magnetic field, stimulating the prefrontal cortex of the brain, a key region involved in mood regulation. While TMS has shown remarkable promise, […]
In March 2019, the U.S. Food and Drug Administration (FDA) marked a significant milestone in the field of mental health by granting approval to esketamine nasal spray, marketed as Spravato®, for the treatment of treatment-resistant depression (TRD) and depressive symptoms in adults with major depressive disorder (MDD) accompanied by suicidal thoughts or actions. Esketamine, the […]
In the realm of mental health, treatment options for individuals diagnosed with major depression has evolved significantly over the years. While traditional approaches like antidepressant medication management have been the cornerstone of treatment, the emergence of innovative methods such as transcranial magnetic stimulation (TMS) has reshaped the landscape, offering hope for those seeking creative treatment options […]
